RTX (RTX), and Northrop Grumman (NOC) — are sliding in Tuesday's session amid escalations in the Middle East conflict after ...
The 2022 case has quietly moved through court for nearly four years, with more than $200,000 in legal fees approved by the ...
Exchanges between two X accounts appear to offer a vivid example of how campaigns may sidestep campaign-finance law to share strategic information.
Remarks the FDA commissioner made during a CNBC appearance seemed to stoke investor fears that UniQure's gene therapy for Huntington's won't get approved.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results